Bosch presents new Xelum R&D for continuous production

Monday May 28, 2018
May 28, 2018 - At Achema 2018, Bosch Packaging Technology will introduce its latest R&D device for the continuous production of oral solid dosage (OSD) forms, describing the platform as ensuring a short time to market and optimum dosing of APIs. With the Xelum R&D, Bosch says it is offering a platform that delivers an ideal start to continuous manufacturing.

As opposed to the common complex mass flow rate, excipients and active ingredients are dosed as a discrete mass in the Xelum R&D, explains the company, making it possible to dose even smallest amounts of APIs of less than one per cent. The system doses, mixes and granulates individual packages, so-called X-keys, which continuously run through the process chain and are removed from the machine as packages into bins. Depending on requirements, up to four loss-in-weight feeders can be used.

Since the Xelum R&D uses the same components for dosing, mixing and granulating as the Xelum production platform from Bosch, process parameters are identical and can be directly transferred 1:1. Material flow from dosing to emptying takes place in a closed process (bin-to-bin). Current continuous production systems for wet granulation mostly use twin screw granulators. The Xelum system relies on fluid bed processors. In the fluid bed, granulation and drying take place in the same process chamber.

Subscription Centre

New Subscription
Already a Subscriber
Customer Service
View Digital Magazine Renew


EMO Hannover 2019
September 16-21, 2019
Weidmuller Open House
September 17, 2019
InfraCanada West
October 1, 2019

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.